001     901854
005     20230217124531.0
024 7 _ |a 10.1111/ene.15072
|2 doi
024 7 _ |a 1351-5101
|2 ISSN
024 7 _ |a 1468-1331
|2 ISSN
024 7 _ |a 1471-0552
|2 ISSN
024 7 _ |a 2128/29184
|2 Handle
024 7 _ |a 34411383
|2 pmid
024 7 _ |a WOS:000692461300001
|2 WOS
037 _ _ |a FZJ-2021-03869
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Kleineberg, Nina N.
|0 P:(DE-Juel1)171203
|b 0
|e Corresponding author
245 _ _ |a Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)
260 _ _ |a Oxford
|c 2021
|b Blackwell Science
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2021-09-03
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2021-12-01
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2021-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1637935400_9026
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Background and purposeDuring acute coronavirus disease 2019 (COVID-19) infection, neurological signs, symptoms and complications occur. We aimed to assess their clinical relevance by evaluating real-world data from a multinational registry.MethodsWe analyzed COVID-19 patients from 127 centers, diagnosed between January 2020 and February 2021, and registered in the European multinational LEOSS (Lean European Open Survey on SARS-Infected Patients) registry. The effects of prior neurological diseases and the effect of neurological symptoms on outcome were studied using multivariate logistic regression.ResultsA total of 6537 COVID-19 patients (97.7% PCR-confirmed) were analyzed, of whom 92.1% were hospitalized and 14.7% died. Commonly, excessive tiredness (28.0%), headache (18.5%), nausea/emesis (16.6%), muscular weakness (17.0%), impaired sense of smell (9.0%) and taste (12.8%), and delirium (6.7%) were reported. In patients with a complicated or critical disease course (53%) the most frequent neurological complications were ischemic stroke (1.0%) and intracerebral bleeding (ICB; 2.2%). ICB peaked in the critical disease phase (5%) and was associated with the administration of anticoagulation and extracorporeal membrane oxygenation (ECMO). Excessive tiredness (odds ratio [OR] 1.42, 95% confidence interval [CI] 1.20–1.68) and prior neurodegenerative diseases (OR 1.32, 95% CI 1.07–1.63) were associated with an increased risk of an unfavorable outcome. Prior cerebrovascular and neuroimmunological diseases were not associated with an unfavorable short-term outcome of COVID-19.ConclusionOur data on mostly hospitalized COVID-19 patients show that excessive tiredness or prior neurodegenerative disease at first presentation increase the risk of an unfavorable short-term outcome. ICB in critical COVID-19 was associated with therapeutic interventions, such as anticoagulation and ECMO, and thus may be an indirect complication of a life-threatening systemic viral infection.
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
542 _ _ |i 2021-09-03
|2 Crossref
|u http://creativecommons.org/licenses/by-nc-nd/4.0/
542 _ _ |i 2021-09-03
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Knauss, Samuel
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Gülke, Eileen
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Pinnschmidt, Hans O.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Jakob, Carolin E. M.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Lingor, Paul
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Hellwig, Kerstin
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Berthele, Achim
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Höglinger, Günter
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 9
|u fzj
700 1 _ |a Endres, Matthias
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Gerloff, Christian
|0 P:(DE-Juel1)178757
|b 11
|u fzj
700 1 _ |a Klein, Christine
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Stecher, Melanie
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Classen, Annika Y.
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Rieg, Siegbert
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Borgmann, Stefan
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Hanses, Frank
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Rüthrich, Maria M.
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Hower, Martin
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Tometten, Lukas
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Haselberger, Martina
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Piepel, Christiane
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Merle, Uta
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Dolff, Sebastian
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Degenhardt, Christian
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Jensen, Björn-Erik O.
|0 P:(DE-HGF)0
|b 26
700 1 _ |a Vehreschild, Maria J. G. T.
|0 P:(DE-HGF)0
|b 27
700 1 _ |a Erber, Johanna
|0 P:(DE-HGF)0
|b 28
700 1 _ |a Franke, Christiana
|0 0000-0002-5609-2472
|b 29
700 1 _ |a Warnke, Clemens
|0 0000-0002-3510-9255
|b 30
773 1 8 |a 10.1111/ene.15072
|b Wiley
|d 2021-09-03
|n 12
|p 3925-3937
|3 journal-article
|2 Crossref
|t European Journal of Neurology
|v 28
|y 2021
|x 1351-5101
773 _ _ |a 10.1111/ene.15072
|g p. ene.15072
|0 PERI:(DE-600)2020241-6
|n 12
|p 3925-3937
|t European journal of neurology
|v 28
|y 2021
|x 1351-5101
856 4 _ |u https://juser.fz-juelich.de/record/901854/files/Kleineberg_2021_Europ%20J%20Neurol_Neurological%20symptoms%20and%20complications....pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:901854
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)171203
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)131720
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 11
|6 P:(DE-Juel1)178757
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NEUROL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-11-20170113
|k INM-11
|l Jara-Institut Quantum Information
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-11-20170113
980 1 _ |a FullTexts
999 C 5 |a 10.1056/NEJMoa2002032
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1007/s00415-020-10067-3
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1212/WNL.0000000000010112
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.neurad.2020.06.007
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S1474-4422(20)30308-2
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1001/jamaneurol.2020.1127
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1177/1747493020959216
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1186/s42466-020-00097-7
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1111/ene.14521
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1097/WCO.0000000000000930
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1212/WNL.0000000000010979
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1136/thoraxjnl-2020-216086
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1001/jama.2020.12603
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.7326/M20-5661
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0140-6736(20)32656-8
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1007/s15010-020-01499-0
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |1 Rahman A
|y 2020
|2 Crossref
|o Rahman A 2020
999 C 5 |a 10.1038/s41586-020-2521-4
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1002/mds.28554
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.3390/jcm9124067
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1111/ene.14690
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1080/00223891.2011.627965
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/s41597-020-00773-y
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1007/s00405-020-05965-1
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1001/jama.2020.6771
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/S0140-6736(20)30566-3
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1001/jama.2020.1585
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1111/jgh.15261
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1212/WNL.0000000000010034
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1212/WNL.0000000000009937
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1186/s13054-020-03077-0
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1136/svn-2020-000431
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.jns.2020.116923
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1161/STROKEAHA.120.030995
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.thromres.2020.04.013
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.jstrokecerebrovasdis.2020.105016
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.ijid.2020.03.062
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1136/bcr-2020-237378
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |1 Sattar SBA
|y 2020
|2 Crossref
|o Sattar SBA 2020
999 C 5 |a 10.1093/infdis/jiaa745
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.jns.2021.117316
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1186/s42466-021-00116-1
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1038/nrgastro.2015.49
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1002/mds.28325
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1007/s00415-020-10070-8
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1001/jamaneurol.2020.2581
|9 -- missing cx lookup --
|2 Crossref
999 C 5 |a 10.1016/j.jns.2020.117147
|9 -- missing cx lookup --
|2 Crossref


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21